Also known as Emend
Aprepitant (Emend (US, EU)) is an antiemetic chemical compound that belongs to a class of drugs called substance P antagonists (SPA). It mediates its effect by blocking the neurokinin 1 (NK1) receptor.Source: Wikipedia
Estimated Total Cost: $183.66 for an average of 7 days supply
Patients are most commonly prescribed aprepitant to treat breast cancer, metastatic cancer, lung cancer, and colorectal cancer.